- Home
- GHRS vs ARR Comparison
GHRS vs ARR Comparison
Compare GHRS & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GHRS | ARR |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2021 | 2009 |
Fundamental Metrics
Financial Performance| Metric | GHRS | ARR |
|---|---|---|
| Price | $23.18 | $14.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $41.38 | $18.50 |
| AVG Volume (30 Days) | 150.4K | ★ 3.7M |
| Earning Date | 05-01-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 16.69% |
| EPS Growth | N/A | ★ 747.06 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.04 | $13.83 |
| 52 Week High | $31.44 | $19.31 |
Technical Indicators
Market Signals| Indicator | GHRS | ARR |
|---|---|---|
| Relative Strength Index (RSI) | 26.61 | 20.14 |
| Support Level | $19.75 | N/A |
| Resistance Level | $25.30 | $17.62 |
| Average True Range (ATR) | 1.29 | 0.32 |
| MACD | -0.50 | -0.13 |
| Stochastic Oscillator | 5.58 | 10.18 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.